Photodynamic therapy for chronic central serous chorioretinopathy

José M. Ruiz-Moreno, Francisco L. Lugo, Felix Armadá, Rufino Silva, Javier A. Montero, J. Fernando Arevalo, Luis Arias, Francisco Gómez-Ulla

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: This study aimed to evaluate the efficacy of photodynamic therapy (PDT) in treating chronic central serous chorioretinopathy (CSC). Methods: We describe a non-randomized, multicentre, interventional case series. A total of 82 eyes of 72 patients with chronic CSC were treated by conventional PDT. LogMAR best corrected visual acuity (BCVA) (ETDRS charts) and central foveal thickness (CFT) measured by optical coherence tomography before and after PDT, number of PDT treatments and complications were used as outcome indicators. Results: Mean follow-up was 12 ± 10 months and mean age was 46 ± 10 years. Mean logMAR BCVA changed from 0.53 (standard deviation [SD] 0.43) before PDT to 0.38 (SD 0.41) at 3 months and 0.48 (SD 0.50) at 6 months (p < 0.0001 and p = 0.007, respectively, Student's t-test for paired data). Mean BCVA at the end of follow-up was 0.37 (SD 0.45; p < 0.0001 from baseline). Macular detachment was resolved and subretinal fluid (SRF) disappeared in all cases. Central foveal thickness decreased from 325 μm (SD 95), to 229 μm (SD 70) at 1 month after PDT, 206 μm (SD 68) at 3 months, and 202 μm (SD 76) at 6 months (all p < 0.0001, Student's t-test for paired data). No cases developed severe visual loss or complications derived from PDT. Reactive retinal pigment epithelium hypertrophy appeared in nine cases after PDT. Conclusions: Photodynamic therapy with verteporfin may be useful in chronic CSC for improving BCVA and reducing SRF and CFT. Randomized studies with longer follow-up are needed to assess the real role of this treatment in chronic CSC.

Original languageEnglish (US)
Pages (from-to)371-376
Number of pages6
JournalActa Ophthalmologica
Volume88
Issue number3
DOIs
StatePublished - May 1 2010
Externally publishedYes

Keywords

  • Central serous chorioretinopathy
  • Optical coherence tomography
  • Photodynamic therapy
  • Retinal pigment epithelium

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Photodynamic therapy for chronic central serous chorioretinopathy'. Together they form a unique fingerprint.

Cite this